Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiaolin Deng

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Cell Stem Cell|September 24, 2013
Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cellsCharlotta Böiers, Joana Carrelha, Michael Lutteropp, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Cancer Cell|May 20, 2014
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivoPetter S Woll, Una Kjällquist, Onima Chowdhury, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Cell Stem Cell|September 24, 2013
Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cellsCharlotta Böiers, Joana Carrelha, Michael Lutteropp, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Cancer Cell|May 20, 2014
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivoPetter S Woll, Una Kjällquist, Onima Chowdhury, et al.
Pageof 10